EP3302485
CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIES
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
27.5.2016EP published:
12.7.2023EP application number:
16804177.0
EPO information:
European Patent Register
Max expiry date:
26.5.2036
Title in English:
CERDULATINIB FOR THE TREATMENT OF B-CELL MALIGNANCIESLanguage of the patent:
English
Timeline
Today
27.5.2016EP application
12.7.2023EP Publication
Owner
Name:
Alexion Pharmaceuticals, Inc.Address:
121 Seaport Boulevard, Boston, MA 02210, US
Inventor
Name:
PANDEY, AnjaliAddress:
South San Francisco, California 94080, US
Name:
COFFEY, GregoryAddress:
South San Francisco, California 94080, US
Name:
LEEDS, JanetAddress:
South San Francisco, California 94080, US
Priority
Number:
201562168530 PDate:
29.5.2015Country:
US
Number:
201562263582 PDate:
4.12.2015Country:
US
Classification
Categories:
A61K 31/506, A61P 35/02